Keyphrases
Multiresistant
100%
Ciprofloxacin
100%
Staphylococcus Epidermidis (S. epidermidis)
100%
Microgram
66%
Axilla
55%
Nostril
44%
Resistant Strains
44%
Minimum Inhibitory Concentration
33%
Antibiotics
22%
Resistance Development
22%
Healthy Individuals
11%
Twice Daily
11%
Days of Treatment
11%
Erythromycin
11%
Gentamicin
11%
Restriction Fragment Length Polymorphism
11%
Healthy People
11%
Oral Administration
11%
Rapid Development
11%
Methicillin
11%
Mean Concentration
11%
Trimethoprim
11%
Ciprofloxacin Resistance
11%
Treatment Development
11%
Sulfonamides
11%
13th
11%
Skin Microbiome
11%
Eccrine Sweat
11%
Nasal Flora
11%
Apocrine Sweat
11%
Medicine and Dentistry
Ciprofloxacin
100%
Sweat
100%
Staphylococcus Epidermidis
100%
Axilla
50%
Antibiotics
20%
Volunteer
10%
Genotype
10%
Restriction Fragment Length Polymorphism
10%
Oral Drug Administration
10%
Trimethoprim
10%
Meticillin
10%
Gentamicin
10%
Sulfonamide
10%
Treatment Development
10%
Erythromycin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ciprofloxacin
100%
Staphylococcus Epidermidis
100%
Tablet
30%
Antibiotics
20%
Normal Human
10%
Erythromycin
10%
Gentamicin
10%
Trimethoprim
10%
Skin Flora
10%
Meticillin
10%
Sulfonamide
10%
Biochemistry, Genetics and Molecular Biology
Ciprofloxacin
100%
Staphylococcus Epidermidis
100%
Minimum Inhibitory Concentration
30%
Genotyping
10%
Normal Human
10%
Gentamicin
10%
Restriction Fragment Length Polymorphism
10%
Trimethoprim
10%
Sulfonamide
10%
Skin Flora
10%
Immunology and Microbiology
Staphylococcus Epidermidis
100%
Axilla
55%
Minimum Inhibitory Concentration
33%
Normal Human
11%
Genotype
11%
Restriction Fragment Length Polymorphism
11%
Skin Flora
11%